Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review

医学 溃疡性结肠炎 人口 自然史 内科学 梅德林 疾病 环境卫生 政治学 法学
作者
Mathurin Fumery,Siddharth Singh,Parambir Singh Dulai,Corinne Gower‐Rousseau,Laurent Peyrin‐Biroulet,William J. Sandborn
出处
期刊:Clinical Gastroenterology and Hepatology [Elsevier BV]
卷期号:16 (3): 343-356.e3 被引量:519
标识
DOI:10.1016/j.cgh.2017.06.016
摘要

A comprehensive knowledge of the natural history of ulcerative colitis (UC) helps understand disease evolution, identify poor prognostic markers and impact of treatment strategies, and facilitates shared decision-making. We systematically reviewed the natural history of UC in adult population-based cohort studies with long-term follow-up.Through a systematic literature review of MEDLINE through March 31, 2016, we identified 60 studies performed in 17 population-based inception cohorts reporting the long-term course and outcomes of adult-onset UC (n = 15,316 UC patients).Left-sided colitis is the most frequent location, and disease extension is observed in 10%-30% of patients. Majority of patients have a mild-moderate course, which is most active at diagnosis and then in varying periods of remission or mild activity; about 10%-15% of patients experience an aggressive course, and the cumulative risk of relapse is 70%-80% at 10 years. Almost 50% of patients require UC-related hospitalization, and 5-year risk of re-hospitalization is ∼50%. The 5-year and 10-year cumulative risk of colectomy is 10%-15%; achieving mucosal healing is associated with lower risk of colectomy. About 50% of patients receive corticosteroids, although this proportion has decreased over time, with a corresponding increase in the use of immunomodulators (20%) and anti-tumor necrosis factor (5%-10%). Although UC is not associated with an increased risk of mortality, it is associated with high morbidity and work disability, comparable to Crohn's disease.UC is a disabling condition over time. Prospective cohorts are needed to evaluate the impact of recent strategies of early use of disease-modifying therapies and treat-to-target approach with immunomodulators and biologics. Long-term studies from low-incidence areas are also needed.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
xiaoliu完成签到,获得积分10
1秒前
以恒之心完成签到,获得积分10
2秒前
思源的应助被hh采纳,获得10
2秒前
Orange的应助被你是我的唯一采纳,获得10
3秒前
wangxinlei发布了新的文献求助10
3秒前
3秒前
zzl完成签到 ,获得积分10
5秒前
aajhajkahna的应助被未见山采纳,获得10
5秒前
5秒前
momo完成签到,获得积分10
5秒前
5秒前
Lin发布了新的文献求助10
5秒前
7秒前
7秒前
欢喜丝发布了新的文献求助10
9秒前
斯文败类的应助被LL采纳,获得10
9秒前
9秒前
gyro发布了新的文献求助10
9秒前
忘忧草完成签到 ,获得积分10
10秒前
10秒前
Joker完成签到,获得积分0
10秒前
luwa关注了科研通微信公众号
11秒前
11秒前
蓝天的应助被zhailingyou采纳,获得10
11秒前
11秒前
12秒前
魔幻灵煌发布了新的文献求助10
12秒前
丘比特的应助被芯子采纳,获得10
12秒前
xcx发布了新的文献求助10
12秒前
三山三完成签到,获得积分10
13秒前
鬼豆完成签到,获得积分10
13秒前
YUAN发布了新的文献求助20
13秒前
13秒前
香蕉觅云的应助被gyro采纳,获得10
14秒前
上官若男的应助被LL采纳,获得10
14秒前
领导范儿的应助被疯狂的雯子采纳,获得10
15秒前
cockcrow完成签到,获得积分20
15秒前
15秒前
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Handbook of Pharmaceutical Excipients. 9th ed 400
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
Breaking the World 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8153710
求助须知:如何正确求助?哪些是违规求助? 9550475
关于积分的说明 21698625
捐赠科研通 7742521
什么是DOI,文献DOI怎么找? 3425571
关于科研通互助平台的介绍 2550735
邀请新用户注册赠送积分活动 2469211